Table 4.

Indications, clinical outcome, and type of implanted IOL in the study participants

Patient	Age/Sex	Possible Causes	Pre-op UCVA	Pre-op BCVA	Post-op UCVA	Post-op BCVA	Targeted SE	Pre-op SE	Post- op SE	Diff SE (Post-op & Targeted)	IOL Type/power
1	6 Mo M	Incorrect keratometry	–	–	–	+3.00	+14.00	+2.00	+1.00	3-piece/ +21.00
2	4 Y F	Known case of PHPV pseudophakic myopic shift	20/800	3/10	2/10	3/10	0.00	-9.50	0.00	0.00	1-piece/ –10.00
3	41 Y F	Biometric error due to chorioretinal coloboma	20/600	5/10	5/10	5/10	0.00	+10.0	0.00	0.00	3-piece/ +15.50
4	71 Y M	Keratometric error due to corneal nebule	2/10	8/10	8/10	8/10	0.00	+5.00	0.00	0.00	3-piece/ +7.50
5	65 Y F	Keratometric error due to KCN	1/10	7/10	7/10	7/10	0.00	+6.50	–0.50	0.00	3-piece/ +10.0
6	70 Y M	Biometric error due to SO	20/400	2/10	2/10	2/10	0.00	+7.00	+0.50	+ 0.50	3-piece/ +10.00
7	47 Y M	(known case of RP) Acceptable RE	3/10	4/10	5/10	4/10	0.00	+2.00	0.00	0.00	3-piece/ +3.00
8	15 Mo M	Known case of PHPV myopic shift	–	–	–	–	+4.00	–500	+3.50	–0.50	1-piece/ –9.00
9	57 Y M	Wrong IOL power, Human error	20/400	4/10	5/10	4/10	0.00	+3.50	0.00	0.00	3-piece/ +5.00
10	11 Y M	Hx of congenital cataract sx, Myopic shift	20/800	2/10	2/10	2/10	0.00	–9.00	0.00	0.00	Sulcuflex/ –10.00
11	64 Y M	Keratometric error due to PMD	1/10	4/10	4/10	4/10	0.00	–7.75	–1.00	–1.00	Sulcoflex/ –8.00
BCVA, best-corrected visual acuity; UCVA, uncorrected visual acuity; SE, spherical error; PHPV, persistent hyperplastic primary vitreous; RP, retinitis pigmentosa; SO, silicon oil; RE, refractive error; sx, surgery; KCN, keratoconus; PMD, pellucid marginal degeneration; IOL, intraocular lens; op, operative; Diff, difference; M, male; F, female; Hx, history of; Mo, month; Y, year